Data gathered: May 17
Alternative Data for Axsome Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 27 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 38,000 | Sign up | Sign up | Sign up |
| Employee Rating | 81 | Sign up | Sign up | Sign up |
| Google Trends | 16 | Sign up | Sign up | Sign up |
| Patents | 243 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 6 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 11,086 | Sign up | Sign up | Sign up |
| Twitter Followers | 368 | Sign up | Sign up | Sign up |
| Twitter Mentions | 25 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 72 | Sign up | Sign up | Sign up |
| Linkedin Employees | 532 | Sign up | Sign up | Sign up |
About Axsome Therapeutics
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States.
| Price | $77.35 |
| Target Price | Sign up |
| Volume | 422,030 |
| Market Cap | $3.61B |
| Year Range | $57.42 - $97.64 |
| Dividend Yield | 0% |
| Revenue per Employee | $611,514 |
| Industry | Biotechnology |
In the news
 |
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $121.92 Average Target Price from BrokeragesMay 12 - ETF Daily News |
 |
Mizuho Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $106.00May 11 - ETF Daily News |
|
Axsome Therapeutics, Inc. (NASDAQ:AXSM) to Post Q2 2024 Earnings of ($1.31) Per Share, HC Wainwright ForecastsMay 10 - ETF Daily News |
|
HC Wainwright Weighs in on Axsome Therapeutics, Inc.’s Q3 2025 Earnings (NASDAQ:AXSM)May 10 - ETF Daily News |
|
Equities Analysts Set Expectations for Axsome Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:AXSM)May 9 - ETF Daily News |
 |
Why Axsome Therapeutics Is A Promising Stock Pick In CNS TreatmentsMay 9 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 69M | 107M | -38M | -68M | -61M | -1.440 |
| Q4 '23 | 66M | 96M | -30M | -99M | -92M | -2.080 |
| Q3 '23 | 53M | 91M | -39M | -62M | -56M | -1.320 |
| Q2 '23 | 47M | 85M | -43M | -67M | -62M | -1.540 |
| Q1 '23 | 95M | 83M | 6.8M | -11M | -2.6M | -0.260 |
Insider Transactions View All
| JEFFS ROGER filed to sell 120,756 shares at $71.6. March 15 '24 |
| JEFFS ROGER filed to sell 120,756 shares at $69.7. March 15 '24 |
| JEFFS ROGER filed to sell 120,756 shares at $69.7. March 15 '24 |
| Coleman Mark filed to sell 25,097 shares at $75.2. September 15 '23 |
Similar companies
Read more about Axsome Therapeutics (AXSM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Axsome Therapeutics?
The Market Cap of Axsome Therapeutics is $3.61B.
How Many People Work at Axsome Therapeutics?
As of our latest update, Axsome Therapeutics employed approximately 383 people worldwide. However, it's important to note that Axsome Therapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Axsome Therapeutics' revenue per employee?
$611,514. To calculate Axsome Therapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Axsome Therapeutics?
Currently, the price of one share of Axsome Therapeutics stock is $77.35.
How can I analyze the AXSM stock price chart for investment decisions?
The AXSM stock price chart above provides a comprehensive visual representation of Axsome Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Axsome Therapeutics shares. Our platform offers an up-to-date AXSM stock price chart, along with technical data analysis and alternative data insights.
Does AXSM offer dividends to its shareholders?
As of our latest update, Axsome Therapeutics (AXSM) does not offer dividends to its shareholders. Investors interested in Axsome Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Axsome Therapeutics?
Some of the similar stocks of Axsome Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.